Corindus Vascular Robotics Inc (CVRS)

[xMalicex]

Revenue totaled $3.0 million during the third quarter, a 78% increase over the prior quarter;
Shipped 524 cassettes in the quarter, a 34% increase over the prior quarter;

next 12 to 24 months. These include performing a live remote case at the upcoming TCT Meeting in San Diego in September; number two, completing the first-in-human remote case in India by the end of the year 2018; number three, completing proof of principle for our neuro system early next year; number four, completing the first-in-human remote case in the U.S. with the neuro wire manipulation in the first half of 2019, and following that, we expect to initiate our Phase I of product development in the second half of 2019; number five, FDA clearance of a neurovascular indication for CorPath GRX in early 2019; and lastly, a potential partnership to codevelop and commercialize a neurovascular product.
Information taken from their earnings call transcript.
They've also hired Citi Bank specifically for this "partnership"